全文获取类型
收费全文 | 35982篇 |
免费 | 2324篇 |
国内免费 | 528篇 |
专业分类
耳鼻咽喉 | 98篇 |
儿科学 | 1549篇 |
妇产科学 | 1328篇 |
基础医学 | 3910篇 |
口腔科学 | 192篇 |
临床医学 | 2100篇 |
内科学 | 4083篇 |
皮肤病学 | 7913篇 |
神经病学 | 2985篇 |
特种医学 | 384篇 |
外国民族医学 | 3篇 |
外科学 | 2507篇 |
综合类 | 3312篇 |
现状与发展 | 4篇 |
预防医学 | 1681篇 |
眼科学 | 117篇 |
药学 | 4648篇 |
13篇 | |
中国医学 | 987篇 |
肿瘤学 | 1020篇 |
出版年
2023年 | 423篇 |
2022年 | 472篇 |
2021年 | 1092篇 |
2020年 | 969篇 |
2019年 | 932篇 |
2018年 | 974篇 |
2017年 | 1057篇 |
2016年 | 973篇 |
2015年 | 960篇 |
2014年 | 1650篇 |
2013年 | 2406篇 |
2012年 | 1470篇 |
2011年 | 1744篇 |
2010年 | 1509篇 |
2009年 | 1443篇 |
2008年 | 1605篇 |
2007年 | 1523篇 |
2006年 | 1492篇 |
2005年 | 1331篇 |
2004年 | 1128篇 |
2003年 | 1120篇 |
2002年 | 951篇 |
2001年 | 922篇 |
2000年 | 748篇 |
1999年 | 727篇 |
1998年 | 668篇 |
1997年 | 649篇 |
1996年 | 685篇 |
1995年 | 605篇 |
1994年 | 595篇 |
1993年 | 516篇 |
1992年 | 524篇 |
1991年 | 481篇 |
1990年 | 485篇 |
1989年 | 426篇 |
1988年 | 379篇 |
1987年 | 347篇 |
1986年 | 342篇 |
1985年 | 421篇 |
1984年 | 344篇 |
1983年 | 255篇 |
1982年 | 274篇 |
1981年 | 201篇 |
1980年 | 199篇 |
1979年 | 176篇 |
1978年 | 154篇 |
1977年 | 129篇 |
1976年 | 106篇 |
1975年 | 81篇 |
1974年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
目的 通过测定生长激素缺乏症 (GHD)患儿用国产重组人生长激素 (recom bined hum angrowth horm one,rh GH)治疗时血清生长激素抗体 (GH- Ab)水平及其结合特性 ,探讨 rh GH的免疫原性及其对疗效的影响。方法 对 6 1例 (男 49例 ,女 12例 ) GHD患儿用国产 rh GH治疗 ,每晚睡前皮下注射 rh GH 0 .1IU /kg共6个月 ;用放射免疫法测定治疗期间患儿血清 GH- Ab水平和滴度 ,并计算抗体结合容量、亲和常数 (Ka)。结果 48%患儿 (2 9/6 1)用药后 3个月血清 GH - Ab呈阳性至试验结束时仍未消失 ,其中 2 0例抗体为弱阳性 (结合率 <10 % ) ,9例呈强阳性 (结合率 >15 % ) ;5 2 %患儿 (32 /6 1)治疗期间抗体为阴性 ;血清 GH- Ab的结合容量、Ka及滴度均为低水平 ,分别为 (0 .1~ 4.8) pmol/L、(1.7× 10 7~ 6 .5× 10 8) L /mol和 1∶ 4~ 1∶ 8。GH- Ab阳性患儿治疗后的身高、身高增长速率及身高落后于正常 SD值的变化与同期阴性者比较无统计学差异 (P>0 .0 5 )。结论 本试验所用国产 rh GH对 GHD患儿身高增长具有确切的促进作用 ,其免疫原性所导致产生的 GH - Ab未对患儿体格线性增长产生负性影响 相似文献
42.
43.
44.
Acute Immobilization Stress and Intraventricular Injection of CRF Suppress Naloxone-Induced LH Release in Ovariectomized Estrogen-Primed Rats 总被引:1,自引:0,他引:1
Tatsuo Akema Atsuhiko Chiba Reiji Shinozaki Morihiro Oshida Fukuko Kimura & Jun-ichi Toyoda 《Journal of neuroendocrinology》1996,8(8):647-652
The present study was undertaken to evaluate the role and possible interaction of the endogenous opioid peptide (EOP) and corticotropin-releasing factor (CRF) in the acute stress-induced suppression of gonadotropin secretion in ovariectomized estrogen-primed rats. An intravenous (i.v.) injection of naloxone (10 or 20 mg/kg), an EOP antagonist, significantly elevated serum luteinizing hormone (LH) levels within 10 min in non-stressed animals. The naloxone-induced LH release was completely eliminated when tested 30 min after the onset of acute immobilization. In a subsequent study, it was found that suppression of the naloxone-induced LH release occurred as early as 5 min after the stress onset, and was still evident 60 min after the end of a 30-min period of immobilization. The effect of naloxone was restored 3 h after liberation of the animal from the 30-min immobilization. An intraventricular (i.c.v.) injection of CRF (1 or 5 μg) also significantly suppressed, in a dose-related manner, the effect of a subsequent i.v. injection of naloxone. However, an i.c.v. injection of α -helical CRF(9-41) (25 or 50 μg), a CRF antagonist, prior to immobilization, could not interfere with the suppressive effect of stress on naloxone-induced LH release. These results suggest that both acute immobilization stress and CRF can inhibit the LH secretory activity without mediation by EOP neurons. However, the stress-related suppression may involve non-CRF mechanism(s). 相似文献
45.
目的:探讨两种剂量的7-甲异炔诺酮(OrgOD14,利维爱)对绝经症状控制的比较。方法:60例绝经后妇女随机分为两组:①A组30例,每日口服7-甲异炔诺酮2.5mg。②B组30例,隔日口服7-甲异炔诺酮2.5mg,共6个月。观察服药前后的Kupperman评分变化及血雌二醇、促卵泡激素水平的改变。结果:两组服药后绝经症状明显改善,Kupperman评分明显降低(P<0.01),雌二醇水平显著上升(P<0.01),促卵泡激素水平明显下降(P<0.05),而两组之间差异无显著性。结论:7-甲异炔诺酮可有效地控制绝经症状,每日口服2.5mg并不比隔日口服2.5mg有较好的控制效果(除控制失眠外),故推荐隔日口服2.5mg7-甲异炔诺酮。 相似文献
46.
Clinical Studies on Functional Dyspepsia Treated with Different Dosage-Form of Zhishi Xiaopi Pill Recipe (枳实消痞丸方) 下载免费PDF全文
Dyspepsiareferstopainordiscomfortfo cusedintheepigastrium,whichwasreportedtooccurinmorethan 1 0 %ofoutpatientsininternalmedicine,andnearlyhalfthepatientsinthegas trointestinal(GI)department(1).Almosthalfofthesepatientswithdyspepsiawhohavenodefi niteorgani… 相似文献
47.
作者用自制的[~(125)I]标记激素,参考国外经验,建立了人血清胰岛素抗体、猪胰岛素原抗体和胰多肽抗体等三种放射免疫检测法,并对方法的主要实验条件进行了优选,对方法的质量控制参数作了验证。结果发现:在使用国产胰岛素的糖尿病人血清中,三种抗体的检出率分别为90.8%、48.3%和36.5%;抗体特异性结合值分别为21.2±17.4%、41.8±27.4%和25.6±28.4;而正常人和糖尿病人未用胰岛素者全部为阴性,显示国产胰岛素具有明显的免疫原性。 相似文献
48.
Enyioma N OBINECHE Michael PT GILLETT Abdishakur ABDULLE Mustapha SULAIMAN Mona AL-ROKHAIMI 《Nephrology (Carlton, Vic.)》2002,7(3):115-120
SUMMARY: In patients with chronic renal failure (CRF), hyperleptinaemia has been widely reported, but the exact mechanisms leading to elevated leptin levels are unclear. Impaired renal clearance of leptin and the influence of other hormones may be important. In this study, we measured serum leptin levels in 150 patients on haemodialysis, peritoneal dialysis or in the predialysis phase of CRF. Furthermore, we measured plasma levels of insulin, growth hormone (GH) and insulin-like growth factor 1 (IGF-1), as well as plasma levels of triacylglycerols and total low density lipoprotein (LDL)- and high density lipoprotein (HDL)-cholesterol. We observed significantly elevated levels of leptin, particularly in female patients, and leptin was shown to correlate significantly with insulin, total and LDL-cholesterol and log triacylglycerols. Leptin was inversely correlated with GH concentrations, but was not correlated with IGF-1 levels. Despite the multiple correlations established between leptin levels and other variables, only hyperinsulinaemia in CRF seems to be important as a determinator of leptin levels. 相似文献
49.
Christopher G. Acker Richard Flick Ron Shapiro Velma P. Scantlebury Mark L. Jordan Carlos Vivas Arthur Greenberg John P. Johnson 《American journal of transplantation》2002,2(1):57-61
Delayed graft function (DGF) in cadaver kidney transplants is a common problem and is often due to acute tubular necrosis (ATN). DGF in transplants may have a deleterious effect on long-term graft survival. Since thyroid hormone has been shown to hasten recovery from ATN in experimental models, we designed a trial to determine if a defined course of triiodothyronine (T3) would improve the short- or long-term outcome of patients with DGF in cadaveric transplants. A prospective, randomized, placebo controlled, double blind trial of T3 was carried out in patients with DGF in cadaveric renal transplants. End-points were percentage requiring dialysis, percentage recovering function, time to recovery and length of hospital stay. Long-term outcomes were percentage grafts functioning at 1 year and mean serum creatinine at 1 year. Forty-four patients were randomized to receive either T3 or placebo. Three patients were dropped from each group when early biopsies disclosed that DGF was due to rejection. The groups were well matched by age, cold ischemia time of the graft, and percentage reactivity to a random panel of antigens. Baseline thyroid function studies, including T3, reverse T3 (rT3), and thyroid stimulating hormone (TSH) levels, were similar between the two groups and typical of 'euthyroid-sick syndrome'. T3 had no effect on percentage requiring dialysis, time to recovery, percentage recovering function, or length of stay. At 1 year follow-up, graft function was similar in both groups and significantly lower than that seen in patients with good initial function. Thyroid hormone, given early in the course of DGF in cadaver kidney recipients, had no effect on the course of DGF. Long-term graft function is impaired in patients who experience post-transplant DGF compared to those who have good initial function. 相似文献
50.
J.P. Thyssen P. Jensen B.C. Carlsen K. Engkilde T. Menné J.D. Johansen 《The British journal of dermatology》2009,161(6):1288-1293
Background Chromium allergy has traditionally been caused by occupational skin contact with cement. In 1983, Danish legislation made the addition of ferrous sulphate compulsory in cement to reduce the water‐soluble chromium content to not more than 2 ppm. An effect from this intervention has previously been demonstrated among Danish construction workers. Objectives To investigate the development of chromium allergy among patients with dermatitis tested between 1985 and 2007 in Denmark. Furthermore, to determine causative exposures in patients with chromium allergy. Patients and methods A retrospective analysis of patch test data was performed (n = 16 228) and charts from patients with chromium allergy were reviewed. Comparisons were made using a χ2 test. Logistic regression analyses were used to test for associations. Results The prevalence of chromium allergy decreased significantly from 3·6% in 1985 to 1% in 1995 (Ptrend < 0·001) but increased to 3·3% in 2007 (Ptrend < 0·001). The frequency of clinically relevant cement exposure decreased significantly among patients with chromium allergy from 12·7% in 1989–1994 to 3·0% (P < 0·01) in 1995–2007, whereas the frequency of relevant leather exposure increased significantly from 24·1% during 1989–1994 to 45·5% during 1995–2007 (P < 0·02). Conclusions Chromium allergy is currently increasing in Denmark due to leather exposure. 相似文献